Skip to main content

Leukotrap WB System - CP2D

NDC 87069-126 · GVS TM INC

FDA carries 2 listing records for this NDC; the most recent is shown.

Generic nameCP2D/AS-3 - Anticoagulant and Additive System
Dosage formSOLUTION
RouteINTRAVENOUS
Active ingredient(s)DEXTROSE, UNSPECIFIED FORM
Strength3.57 g/70mL
Marketing categoryNDA

Packages

87069-126-63 — 6 POUCH in 1 CARTON (87069-126-63) / 3 BAG in 1 POUCH / 70 mL in 1 BAG

87069-126-62 — 6 POUCH in 1 CARTON (87069-126-62) / 3 BAG in 1 POUCH / 70 mL in 1 BAG

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0536-1302 — dextrose(glucose),Levulose(fructose),Phosphoric acid, 30142-708 — Dextrose(glucose),Levulose(fructose),Phosphoric acid, 36800-708 — phosphorated carbohydrate, 37808-883 — Dextrose(glucose),Levulose(fructose),Phosphoric acid, 41250-495 — Dextrose(glucose),Levulose(fructose),Phosphoric acid, 46122-729 — dextrose(glucose),Levulose(fructose),Phosphoric acid, 53943-708 — dextrose(glucose),Levulose(fructose),Phosphoric acid, 63868-704 — dextrose(glucose),Levulose(fructose),Phosphoric acid, 63941-708 — dextrose(glucose),Levulose(fructose),Phosphoric acid, 68016-807 — dextrose(glucose),Levulose(fructose),Phosphoric acid, 69842-708 — Dextrose(glucose),Levulose(fructose),Phosphoric acid, 70000-0052 — dextrose(glucose),Levulose(fructose),Phosphoric acid, 83324-217 — dextrose(glucose),Levulose(fructose),Phosphoric acid, 87069-121 — CP2D/AS-3 triple with sampling system, 87069-123 — CP2D/AS-3 Anticoagulant and Additive System, 87069-129 — CP2D/AS-3 Anticoagulant and Additive System, 87069-455 — CP2D, 87069-460 — AS-3, 87069-462 — AS-3, 87069-726 — CP2D/AS-3 Anticoagulant and Additive System, +17 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels